ASX - By Stock
|
AN1 |
Re:
AFR Exclusive
|
|
maldowl
|
86 |
24K |
0 |
04/04/22 |
04/04/22 |
ASX - By Stock
|
86
|
24K
|
0
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Agreement Signed for Sale of Lyramid Limited
|
|
maldowl
|
333 |
54K |
6 |
14/05/21 |
14/05/21 |
ASX - By Stock
|
333
|
54K
|
6
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Rights Issue Closed with Strong Demand
|
|
maldowl
|
154 |
27K |
6 |
15/04/21 |
15/04/21 |
ASX - By Stock
|
154
|
27K
|
6
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Rights Issue Closed with Strong Demand
|
|
maldowl
|
154 |
27K |
0 |
08/04/21 |
08/04/21 |
ASX - By Stock
|
154
|
27K
|
0
|
|
ASX - By Stock
|
AN1 |
Re:
Midkine and COVID 19
|
|
maldowl
|
72 |
14K |
12 |
23/03/21 |
23/03/21 |
ASX - By Stock
|
72
|
14K
|
12
|
|
ASX - By Stock
|
AN1 |
Re:
2021 - a New Beginning
|
|
maldowl
|
61 |
12K |
5 |
18/02/21 |
18/02/21 |
ASX - By Stock
|
61
|
12K
|
5
|
|
ASX - By Stock
|
AN1 |
Re:
2021 - a New Beginning
|
|
maldowl
|
61 |
12K |
5 |
17/02/21 |
17/02/21 |
ASX - By Stock
|
61
|
12K
|
5
|
|
ASX - By Stock
|
AN1 |
Re:
2021 - a New Beginning
|
|
maldowl
|
61 |
12K |
1 |
15/02/21 |
15/02/21 |
ASX - By Stock
|
61
|
12K
|
1
|
|
ASX - By Stock
|
AN1 |
Re:
2021 - a New Beginning
|
|
maldowl
|
61 |
12K |
6 |
15/02/21 |
15/02/21 |
ASX - By Stock
|
61
|
12K
|
6
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid Publishes Data on Novel Proprietary FGF5 Aptamer
|
|
maldowl
|
29 |
6.3K |
2 |
10/02/21 |
10/02/21 |
ASX - By Stock
|
29
|
6.3K
|
2
|
|
ASX - By Stock
|
AN1 |
??
|
|
maldowl
|
50 |
9.7K |
5 |
02/02/21 |
02/02/21 |
ASX - By Stock
|
50
|
9.7K
|
5
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Change of Director's Interest Notice - King
|
|
maldowl
|
3 |
1.3K |
4 |
30/12/20 |
30/12/20 |
ASX - By Stock
|
3
|
1.3K
|
4
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid Signs 10 Year Chinese Distribution Agreement
|
|
maldowl
|
53 |
13K |
1 |
14/12/20 |
14/12/20 |
ASX - By Stock
|
53
|
13K
|
1
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid Signs 10 Year Chinese Distribution Agreement
|
|
maldowl
|
53 |
13K |
0 |
14/12/20 |
14/12/20 |
ASX - By Stock
|
53
|
13K
|
0
|
|
ASX - By Stock
|
AN1 |
Re:
Amazon
|
|
maldowl
|
38 |
7.7K |
0 |
07/12/20 |
07/12/20 |
ASX - By Stock
|
38
|
7.7K
|
0
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Initial Director's Interest Notice - Eck-Thompson
|
|
maldowl
|
13 |
2.4K |
4 |
03/12/20 |
03/12/20 |
ASX - By Stock
|
13
|
2.4K
|
4
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Initial Director's Interest Notice - Eck-Thompson
|
|
maldowl
|
13 |
2.4K |
4 |
03/12/20 |
03/12/20 |
ASX - By Stock
|
13
|
2.4K
|
4
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Annual General Meeting Update
|
|
maldowl
|
30 |
4.5K |
4 |
01/12/20 |
01/12/20 |
ASX - By Stock
|
30
|
4.5K
|
4
|
|
ASX - By Stock
|
AN1 |
Re:
Midkine News 2020
|
|
maldowl
|
37 |
10K |
4 |
23/10/20 |
23/10/20 |
ASX - By Stock
|
37
|
10K
|
4
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Date of Annual General Meeting
|
|
maldowl
|
11 |
3.2K |
4 |
16/10/20 |
16/10/20 |
ASX - By Stock
|
11
|
3.2K
|
4
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Date of Annual General Meeting
|
|
maldowl
|
11 |
3.2K |
4 |
15/10/20 |
15/10/20 |
ASX - By Stock
|
11
|
3.2K
|
4
|
|
ASX - By Stock
|
AN1 |
Re:
How Much is Cellmid's (ASX:CDY) CEO Getting Paid?
|
|
maldowl
|
5 |
1.7K |
2 |
30/09/20 |
30/09/20 |
ASX - By Stock
|
5
|
1.7K
|
2
|
|
ASX - By Stock
|
AN1 |
Re:
$1 Here We Come
|
|
maldowl
|
81 |
20K |
2 |
24/09/20 |
24/09/20 |
ASX - By Stock
|
81
|
20K
|
2
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Annual Report to shareholders
|
|
maldowl
|
22 |
6.4K |
4 |
17/09/20 |
17/09/20 |
ASX - By Stock
|
22
|
6.4K
|
4
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Annual Report to shareholders
|
|
maldowl
|
22 |
6.4K |
1 |
15/09/20 |
15/09/20 |
ASX - By Stock
|
22
|
6.4K
|
1
|
|
ASX - By Stock
|
AN1 |
Re:
Is this it?
|
|
maldowl
|
104 |
35K |
4 |
12/09/20 |
12/09/20 |
ASX - By Stock
|
104
|
35K
|
4
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: CDY Engages Advisers to Facilitate Divestment from Lyramid
|
|
maldowl
|
139 |
28K |
3 |
11/09/20 |
11/09/20 |
ASX - By Stock
|
139
|
28K
|
3
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: CDY Engages Advisers to Facilitate Divestment from Lyramid
|
|
maldowl
|
139 |
28K |
3 |
11/09/20 |
11/09/20 |
ASX - By Stock
|
139
|
28K
|
3
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: CDY Engages Advisers to Facilitate Divestment from Lyramid
|
|
maldowl
|
139 |
28K |
3 |
10/09/20 |
10/09/20 |
ASX - By Stock
|
139
|
28K
|
3
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: FY20 Results Presentation
|
|
maldowl
|
52 |
9.8K |
6 |
28/08/20 |
28/08/20 |
ASX - By Stock
|
52
|
9.8K
|
6
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: FY20 Results Presentation
|
|
maldowl
|
52 |
9.8K |
5 |
28/08/20 |
28/08/20 |
ASX - By Stock
|
52
|
9.8K
|
5
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: FY20 Results Presentation
|
|
maldowl
|
52 |
9.8K |
5 |
27/08/20 |
27/08/20 |
ASX - By Stock
|
52
|
9.8K
|
5
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: FY20 Results Presentation
|
|
maldowl
|
52 |
9.8K |
8 |
27/08/20 |
27/08/20 |
ASX - By Stock
|
52
|
9.8K
|
8
|
|
ASX - By Stock
|
AN1 |
Re:
Post-market evaluation of serology-based point of care tests
|
|
maldowl
|
71 |
20K |
3 |
20/08/20 |
20/08/20 |
ASX - By Stock
|
71
|
20K
|
3
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Appendix 4C and Quarterly Activity Report
|
|
maldowl
|
28 |
6.3K |
5 |
23/07/20 |
23/07/20 |
ASX - By Stock
|
28
|
6.3K
|
5
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Extension Of Wondfo Rapid Test Distribution Agreement
|
|
maldowl
|
41 |
10K |
1 |
20/07/20 |
20/07/20 |
ASX - By Stock
|
41
|
10K
|
1
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid Signs Exclusive Agreement For Sars-Cov-2 Laboratory
|
|
maldowl
|
43 |
11K |
3 |
15/07/20 |
15/07/20 |
ASX - By Stock
|
43
|
11K
|
3
|
|
ASX - By Stock
|
AN1 |
Re:
Midkine News 2020
|
|
maldowl
|
37 |
10K |
7 |
13/07/20 |
13/07/20 |
ASX - By Stock
|
37
|
10K
|
7
|
|
ASX - By Stock
|
AN1 |
Re:
News: CDY Cellmid Says Signed Exclusive Distribution Agreement With Immunodiagnostics, HK
|
|
maldowl
|
3 |
855 |
5 |
09/07/20 |
09/07/20 |
ASX - By Stock
|
3
|
855
|
5
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Pause in Trading
|
|
maldowl
|
34 |
7.5K |
4 |
07/07/20 |
07/07/20 |
ASX - By Stock
|
34
|
7.5K
|
4
|
|
ASX - By Stock
|
AN1 |
Re:
When will CDY start trading again?
|
|
maldowl
|
35 |
12K |
12 |
29/05/20 |
29/05/20 |
ASX - By Stock
|
35
|
12K
|
12
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Suspension from Official Quotation
|
|
maldowl
|
162 |
48K |
5 |
12/05/20 |
12/05/20 |
ASX - By Stock
|
162
|
48K
|
5
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid Signs COVID-19 Rapid Diagnostic Supply Agreement
|
|
maldowl
|
1.2K |
408K |
1 |
06/05/20 |
06/05/20 |
ASX - By Stock
|
1.2K
|
408K
|
1
|
|
ASX - By Stock
|
AN1 |
Re:
India cancels orders for Chinese Covid-19 test kits, says won't lose money
|
|
maldowl
|
39 |
9.4K |
0 |
02/05/20 |
02/05/20 |
ASX - By Stock
|
39
|
9.4K
|
0
|
|
ASX - By Stock
|
AN1 |
Re:
Ventilators, Midkine, Mechanical Stress and the Induction of Lung Fibrosis
|
|
maldowl
|
3 |
1.3K |
2 |
16/04/20 |
16/04/20 |
ASX - By Stock
|
3
|
1.3K
|
2
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid Signs COVID-19 Rapid Diagnostic Supply Agreement
|
|
maldowl
|
1.2K |
408K |
12 |
10/04/20 |
10/04/20 |
ASX - By Stock
|
1.2K
|
408K
|
12
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid Signs COVID-19 Rapid Diagnostic Supply Agreement
|
|
maldowl
|
1.2K |
408K |
17 |
09/04/20 |
09/04/20 |
ASX - By Stock
|
1.2K
|
408K
|
17
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid Signs COVID-19 Rapid Diagnostic Supply Agreement
|
|
maldowl
|
1.2K |
408K |
2 |
09/04/20 |
09/04/20 |
ASX - By Stock
|
1.2K
|
408K
|
2
|
|
Food & Nutrition
|
|
Re:
Strengthen immune System howto
|
|
maldowl
|
18 |
7.7K |
1 |
07/04/20 |
07/04/20 |
Food & Nutrition
|
18
|
7.7K
|
1
|
|
ASX - By Stock
|
HGV |
Re:
Ann: Harvest One update on strategic review and half year results
|
|
maldowl
|
5 |
2.9K |
1 |
05/03/20 |
05/03/20 |
ASX - By Stock
|
5
|
2.9K
|
1
|
|